Delaware
|
001-33380
|
87-0792558
|
||
(State or Other Jurisdiction
of Incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 2.02
|
Results of Operations and Financial Condition.
|
Item 9.01
|
Financial Statements and Exhibits.
|
|
99.1
|
Press Release of PharMerica Corporation dated August 5, 2010.
|
PHARMERICA CORPORATION | ||
Date: August 5, 2010
|
By:
|
/s/ Michael J. Culotta
|
Michael J. Culotta
|
||
Executive Vice President and Chief Financial Officer
|
Exhibit No.
|
Description
|
99.1
|
Press Release of PharMerica Corporation dated August 5, 2010.
|